Speciation of arsenic trioxide metabolites in peripheral blood and bone marrow from an acute promyelocytic leukemia patient.
about
Metabolism, toxicity and anticancer activities of arsenic compounds.The potential role of infectious agents and pelvic inflammatory disease in ovarian carcinogenesisMass spectrometry in leukemia research and treatment.Induction by arsenate of cell-type-specific cytotoxic effects in nerve and hepatoma cells.Arsenic disulfide-triggered apoptosis and erythroid differentiation in myelodysplastic syndrome and acute myeloid leukemia cell lines.Different Culture Media Affect Proliferation, Surface Epitope Expression, and Differentiation of Ovine MSC.Relationship of different platelet response criteria and patient outcomes in a romiplostim myelodysplastic syndromes trial.β-Catenin Accumulation Is Associated With Increased Expression of Nanog Protein and Predicts Maintenance of MSC Self-Renewal.Thymidine kinase 1 expression in ovarian serous adenocarcinoma is superior to Ki-67: A new prognostic biomarker.Quercetin potentiates transdifferentiation of bone marrow mesenchymal stem cells into the beta cells in vitro.Fludarabine inhibits STAT1-mediated up-regulation of caspase-3 expression in dexamethasone-induced osteoblasts apoptosis and slows the progression of steroid-induced avascular necrosis of the femoral head in rats.Antitumor activity of arsenite in combination with tetrandrine against human breast cancer cell line MDA-MB-231 in vitro and in vivo
P2860
Q33618916-88F786C7-693A-45B6-B598-9DAC72A84038Q33705880-580E5CF3-6A02-4053-925D-F03BA7BB0415Q38365432-FE02B1E8-0E77-473F-B669-8C41339AAE4AQ39029781-8367CAA6-4D6F-4027-B40C-E8F134DCA461Q39066853-30C23950-F0FF-47A5-80C4-CA7E19A44D27Q42920144-7A6DF75A-359F-47DF-A8B9-0C02D4CCAB1EQ43077299-205942DE-5648-415F-9916-D37EBB79782DQ47110007-B637B3E0-4B29-4250-B64C-B68BB6A7580DQ50922678-BBFDA6CF-7425-4F6D-8EE7-1C8655F48742Q51246109-ADA6E097-56EC-4B2E-976B-D8A8EF10F273Q52860832-2ABD6835-03EF-4C57-A72F-7CF9CCEA1D82Q58786173-D3754A98-390E-4FCF-95BA-9788D959A073
P2860
Speciation of arsenic trioxide metabolites in peripheral blood and bone marrow from an acute promyelocytic leukemia patient.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
Speciation of arsenic trioxide ...... romyelocytic leukemia patient.
@ast
Speciation of arsenic trioxide ...... romyelocytic leukemia patient.
@en
type
label
Speciation of arsenic trioxide ...... romyelocytic leukemia patient.
@ast
Speciation of arsenic trioxide ...... romyelocytic leukemia patient.
@en
prefLabel
Speciation of arsenic trioxide ...... romyelocytic leukemia patient.
@ast
Speciation of arsenic trioxide ...... romyelocytic leukemia patient.
@en
P2093
P2860
P356
P1476
Speciation of arsenic trioxide ...... romyelocytic leukemia patient.
@en
P2093
Akira Horikoshi
Hiroo Toyoda
Jin Takeuchi
Noriyoshi Iriyama
Yoshihiro Hatta
Yukio Hirabayashi
Yuta Yoshino
P2860
P2888
P356
10.1186/1756-8722-5-1
P577
2012-01-24T00:00:00Z
P5875
P6179
1009639206